Diffuse Large B-cell Lymphoma: Loncastuximab and Epcoritamab Study

We are studying a combination of two medications for patients with relapsed or refractory diffuse large B-cell lymphoma. The goal is to see how well this treatment works and its safety compared to existing options.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Zynlonta
Zynlonta is a cancer medicine used to treat certain aggressive large B‑cell lymphomas when other treatments have not worked.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Epcoritamab
Epcoritamab is a lab-made antibody that helps the immune system target and kill cancerous B cells in certain types of non-Hodgkin lymphoma.
Loncastuximab Tesirine
Loncastuximab tesirine is an antibody-based treatment that targets CD19 on cancerous B cells to destroy certain aggressive B-cell lymphomas.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Vivantes Netzwerk fuer Gesundheit GmbH
Hematology, Oncology and palliative care
Berlin, Germany
HELIOS Klinikum Berlin-Buch GmbH
Clinic for Hematology and Stem Cell Transplantation
Bernau bei Berlin, Germany
Evangelisches Klinikum Bethel gGmbH
Dept. of Hematology/Medical Oncology
Bielefeld, Germany

Sponsor: Universitaet Muenster
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.